$400 million funding boost for medical research

Health Industry Hub | May 22, 2020 |
[Total: 1    Average: 5/5]

The Morrison Government will invest almost $400 million in world-leading health and medical research projects to improve the lives of all Australians.

A total of 237 new projects will receive funding from the National Health and Medical Research Council (NHMRC), with a further 30 grants to be funded through the Medical Research Future Fund (MRFF) Priority Round.

Funding will support research in the areas of:

  • Cancer – $87.1 million
  • Cardiovascular Disease – $46.5 million
  • Mental health – $54.0 million
  • Indigenous – $19.4 million
  • Infectious diseases – $84.7 million

Of the grants funded, a total of $84.7 million will go towards 61 new research projects in infectious diseases.

Register FREE & join 22,000+ industry professionals in reading the latest industry news & engaging content from Health Industry Hub, the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.

Whilst applications for this grant round closed in 2019, prior to the outbreak of COVID-19, infectious disease research into influenza and pneumonia may contribute to our understanding of COVID-19 and translate into new treatment strategies and trials.

Professor Allen Cheng from Monash University will receive $1.7 million to optimise vaccine and treatment strategies to prevent illness and death from severe influenza in Australia.

Professor Cheng’s research project will transform the prevention and treatment of influenza and its complications by developing innovative public health and treatment strategies that can be applied globally.

Australians will benefit from this vital health and medical research being conducted around the country:

  • $186 million in research funding for 124 projects in Victoria, including University of Melbourne research to put 3D printing into the reality of surgery by developing an approach for regenerating joint cartilage within the body using one-step surgery
  • $119.8 million in research funding for 83 projects in New South Wales, including University of New South Wales research to explore how novel internet solutions can be used
    to overcome the burden of depression in youth.
  • $48.8 million in research funding for 29 projects in Queensland, including QIMR Berghofer Institute of Medical Research research into the genetic basis of breast cancer risk with the
    aim of reducing breast cancer incidence and mortality.
  • $24.1 million in research funding for 15 projects in South Australia, including University of South Australia research into the monitoring of medical conditions such as preeclampsia, epilepsy, fetal arrhythmias and heart attacks through advanced technologies that can be integrated with point-of-care and wearable diagnostic tools.
  • $8.4 million in research funding for nine projects in Western Australia, including University of Western Australia research into novel and effective chemotherapy and immunotherapy drug combinations to reduce deaths from cancer.
  • $5.6 million in research funding for five projects in the Northern Territory, including Menzies School of Health Research work towards the elimination of chronic hepatitis B in the Northern Territory.
  • $3.8 million in research funding for two projects in the ACT, including Australian National University research to strengthen the detection and prediction of outbreaks of emerging infectious diseases, and the control and elimination of neglected tropical diseases.

While this round was closed for submissions last year, the Government is currently in the process of awarding $42 million for COVID research through the MRFF.

About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

Leadership & Management

Leadership Management Qualities - COVID-19 wiping out hard-won gains by women in STEM

COVID-19 wiping out hard-won gains by women in STEM

Health Industry Hub | June 1, 2020 |

Hard-won gains for women’s advancement in the science, technology, engineering and maths (STEM) workforce are now at risk of a […]


News & Trends - Medical Technology

MedTech News - New agreement to end public hospitals' “harvesting” of privately insured patients

New agreement to end public hospital “harvesting” of privately insured patients

Health Industry Hub | June 1, 2020 |

MedTech News: The new National Health Reform Agreement has the potential to end the practice of public hospitals “harvesting” privately […]


News & Trends - Pharmaceuticals

Pharma News - GSK's targeted therapy for asthma gains PBS listing for self-administration delivery

GSK’s targeted therapy for asthma gains PBS listing for self-administration delivery

Health Industry Hub | June 1, 2020 |

Pharma News: From 1 June 2020, GSK Australia’s new pre-filled pen (autoinjector) for the self-administration of its targeted therapy for […]


News & Trends - Pharmaceuticals

Pharma News - Major changes to opioid PBS listings effective 1 June

Major changes to opioid PBS listings effective 1 June

Health Industry Hub | June 1, 2020 |

Commencing 1 June 2020, the Pharmaceutical Benefits Scheme (PBS) listings for opioid medicines will change including Tramal (tramadol) and Panadeine […]